Remove Anthem Remove Blogging Remove Marketing Remove Pricing
article thumbnail

Anthem Caps Coverage Of Biogen Spine Drug Despite Wide FDA Approval

Xconomy

One of the nation’s major health insurers has placed limitations on access to the first-ever approved drug for the rare spinal muscular atrophy, validating patient fears that the high price tag of the drug, nusinersen (Spinraza), might make it hard for some with the disease to get treatment.

Anthem 40
article thumbnail

This Week in VC with Farb Nivi, Founder of Grockit

Both Sides of the Table

I don’t do advertising on my blog, but I thought it was worth mentioning Ryan in particular because he has an alternate model for doing a startup. Pricing engine helps publishers ascertain ad inventory pricing by analyzing ad transaction data from the market/exchanges. They sponsor TWiVC. MetaMarkets.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

This Week in VC with Om Malik & Paul Jozefak

Both Sides of the Table

The strategy of GigaOm and where they differentiate in the market. An investment doesn’t guarantee your product will suddenly be on the investor’s price sheet. Diverse search results include stream updates, blog posts, news articles, photos, videos (versus Twitter/FaceBook1 only). Total raised: $5.0mm.

article thumbnail

Bio Roundup: Trump News, Anthem’s Stand, Diversity by 2056 & More

Xconomy

And a group of biotechs led by Jounce Therapeutics were the first to test the IPO market in 2017. A flurry of deals took place, headlined by Johnson & Johnson’s $30 billion gamble on Swiss firm Actelion. Meanwhile in Washington, President Donald Trump spent much of his first week signing executive orders on a variety of.

News 40